- Home
- NNNN vs CUBI Comparison
NNNN vs CUBI Comparison
Compare NNNN & CUBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NNNN
- CUBI
- Stock Information
- Founded
- NNNN 2021
- CUBI 1994
- Country
- NNNN Germany
- CUBI United States
- Employees
- NNNN N/A
- CUBI N/A
- Industry
- NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- CUBI Major Banks
- Sector
- NNNN Health Care
- CUBI Finance
- Exchange
- NNNN Nasdaq
- CUBI Nasdaq
- Market Cap
- NNNN 2.2B
- CUBI 2.2B
- IPO Year
- NNNN 2025
- CUBI 2012
- Fundamental
- Price
- NNNN $28.10
- CUBI $64.56
- Analyst Decision
- NNNN
- CUBI Strong Buy
- Analyst Count
- NNNN 0
- CUBI 8
- Target Price
- NNNN N/A
- CUBI $74.50
- AVG Volume (30 Days)
- NNNN 82.0K
- CUBI 305.2K
- Earning Date
- NNNN 10-23-2025
- CUBI 10-30-2025
- Dividend Yield
- NNNN N/A
- CUBI N/A
- EPS Growth
- NNNN N/A
- CUBI N/A
- EPS
- NNNN 0.06
- CUBI 4.05
- Revenue
- NNNN $8,185,146.00
- CUBI $596,459,000.00
- Revenue This Year
- NNNN N/A
- CUBI $16.37
- Revenue Next Year
- NNNN N/A
- CUBI $6.49
- P/E Ratio
- NNNN $566.20
- CUBI $15.99
- Revenue Growth
- NNNN 21.95
- CUBI N/A
- 52 Week Low
- NNNN $5.18
- CUBI $40.75
- 52 Week High
- NNNN $55.65
- CUBI $72.51
- Technical
- Relative Strength Index (RSI)
- NNNN 38.40
- CUBI 43.59
- Support Level
- NNNN $28.13
- CUBI $63.76
- Resistance Level
- NNNN $33.32
- CUBI $66.99
- Average True Range (ATR)
- NNNN 5.89
- CUBI 1.59
- MACD
- NNNN -0.54
- CUBI -0.20
- Stochastic Oscillator
- NNNN 26.27
- CUBI 21.82
About NNNN Anbio Biotechnology Class A Ordinary Shares
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.
About CUBI Customers Bancorp Inc
Customers Bancorp Inc is a bank holding company engaged in banking activities. It provides financial products and services to small and middle-market businesses, not-for-profits, and consumers. The company operates in Lending Activities, Commercial Lending, Consumer Lending, Private Banking, Deposit Products, Other Funding Sources and Financial Products and Services. The majority of revenue is derived from commercial lending.